Industries > Pharma > Behavioural Health Market Report to 2031
Behavioural Health Market Report to 2031
By Service Type (Inpatient Hospital Treatment, Outpatient Counselling, Home-Based Treatment Services, Emergency Mental Health Services, Intensive Care Management), By Disorder (Anxiety Disorder, Bipolar Disorder, Depression, Eating Disorder, Post-Traumatic Stress Disorder, Substance Abuse Disorder), By End User (Outpatient Clinics, Rehabilitation Centers, Hospitals (Emergency), Homecare Setting) And Leading Regional/ Country Market Analysis
Global Behavioral Health Market– our new study reveals trends, R&D progress, and predicted revenues
Where is the Global Behavioral Health market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2031, assessing data, trends, opportunities, and business prospects there.
Discover how to stay ahead
Our Global Behavioral Health page report provides tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Global Behavioral Health Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analysis (including market dynamics, drivers, opportunities, restraints, and challenges), product profiles and recent developments.
Global Behavioral Health: By Service Type
• Inpatient Hospital Treatment
• Outpatient Counselling
• Home-Based Treatment Services
• Emergency Mental Health Services
• Intensive Care Management
Global Behavioral Health: By Disorder
• Anxiety Disorder
• Bipolar Disorder
• Depression
• Eating Disorder
• Post-Traumatic Stress Disorder
• Substance Abuse Disorder
• Others
Global Behavioral Health: By End User
• Outpatient Clinics
• Rehabilitation Centers
• Hospitals (Emergency)
• Homecare Setting
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin America
• Middle East and Africa
o Turkey
o Saudi Arabia
o South Africa
o UAE
o Egypt
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Global Behavioral Health Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Global Behavioral Health Market will surpass $XXX million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Global Behavioral Health Market report helps you
In summary, our 255+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Global Behavioral Health Market, with forecasts for Service Type, By Disorder, and End User, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 16 key national markets – See forecasts for the Global Behavioral Health market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for Global Behavioral Health of the major companies involved in the Global Behavioral Health Market. Some of the company’s profiled in this report include Cerner, Netsmart, Core Solutions, Mindlinc, Nextgen Healthcare, The Echo Group, Valant, Welligent, Qualifacts, Credible, Pfizer, Inc., F. Hoffman-La Roche AG, Bristol-Myers Squibb Company, Teva Pharmaceuticals Industries Ltd., Eli Lilly and Company, Novartis AG, Meditab, Kareo, Compulink, Advance Data Systems, among others.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Global Behavioral Health Market and leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Behavioral Health Market Report to 2031: By Service Type (Inpatient Hospital Treatment, Outpatient Counselling, Home-Based Treatment Services, Emergency Mental Health Services, Intensive Care Management), By Disorder (Anxiety Disorder, Bipolar Disorder, Depression, Eating Disorder, Post-Traumatic Stress Disorder, Substance Abuse Disorder), By End User (Outpatient Clinics, Rehabilitation Centers, Hospitals (Emergency), Homecare Setting) And Leading Regional/ Country Market Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. What is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Global Behavioral Health Market
2.1. Behavioral Health Market Definition
2.2. Service Type Submarkets Definitions
2.3. Disorder Submarkets Definitions
2.4. End User Submarkets Definitions
3. Global Behavioral Health Market Overview
3.1. Global Behavioral Health Market Size and Forecast by Region
3.2. Global Behavioral Health Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Rising Mental Disorders Around the Globe
3.3.1.2. Increasing Awareness for Behavioral Health
3.3.1.3. Cohesive Reimbursement Policies
3.3.1.4. Increasing Investment in R&D
3.3.2. Market Restraints/Challenges
3.3.2.1. High Cost of treatment
3.3.2.2. Side Effects Associated with the Treatment
3.3.3. Opportunities
3.3.3.1. Healthcare Reforms in Emerging Economies
3.3.3.2. Technological Advancement and Innovation
3.3.3.3. Rising New Entrants
4. Global Behavioral Health Market Analysis and Forecast 2021-2031, by Service Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Inpatient Hospital Treatment
4.1.1.1. New Development in Therapies
4.1.2. Outpatient Counselling
4.1.2.1. Increasingly Adopted Around the Globe
4.1.3. Home-Based Treatment Services
4.1.3.1. Considerable Success Rate
4.1.4. Others
5. Global Behavioral Health Market Analysis and Forecast, 2021-2031 by Disorder (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Anxiety Disorder
5.1.1.1. Increasing work pressure at office
5.1.2. Bipolar Disorder
5.1.2.1. Rising mental stress
5.1.3. Depression
5.1.3.1. Unfavorable lifestyle changes and mental stress
5.1.4. Eating Disorder
5.1.4.1. Unhealthy lifestyle
5.1.5. Post-Traumatic Stress Disorder
5.1.5.1. Rising accidents and tragedies
5.1.6. Substance Abuse Disorder
5.1.6.1. Youths are inclined towards drugs and substance abuse
6. Global Behavioral Health Market Analysis and Forecast, 2021-2031 by End User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Outpatient Clinics
6.1.2. Rehabilitation Centers
6.1.3. Hospitals (Emergency)
6.1.4. Homecare Settings
7. North America Behavioral Health Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. North America Behavioral Health Market Size and Forecast by Service Type
7.3. North America Behavioral Health Market Size and Forecast by Disorder
7.4. North America Behavioral Health Market Size and Forecast by End User
7.5. U.S. Behavioral Health Market
7.5.1. Rising Adoption of Stress Relieving Therapies and Applications
7.6. Canada Behavioral Health Market
7.6.1. Rising Incidence and Prevalence of Depression and Mental Disorders
8. Europe Behavioral Health Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Europe Behavioral Health Market Size and Forecast by Service Type
8.3. Europe Behavioral Health Market Size and Forecast by Disorder
8.4. Europe Behavioral Health Market Size and Forecast by End User
8.5. UK Behavioral Health Market
8.6. Germany Behavioral Health Market
8.7. France Behavioral Health Market
8.8. Rest of Europe Behavioral Health Market
9. Asia Pacific Behavioral Health Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Asia Pacific Behavioral Health Market Size and Forecast by Service type
9.3. Asia Pacific Behavioral Health Market Size and Forecast by Disorder
9.4. Asia Pacific Behavioral Health Market Size and Forecast by End User
9.5. China Behavioral Health Market
9.6. India Behavioral Health Market
9.7. Japan Behavioral Health Market
9.8. Rest of Asia Pacific Behavioral Health Market
10. Latin America Behavioral Health Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Latin America Behavioral Health Market Size and Forecast by Service type
10.3. Latin America Behavioral Health Market Size and Forecast by Disorder
10.4. Latin America Behavioral Health Market Size and Forecast by End User
10.4.1. Brazil Behavioral Health Market
10.4.2. Mexico Behavioral Health Market
10.4.3. Rest of Latin America Behavioral Health Market
11. MEA Behavioral Health Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. MEA Behavioral Health Market Size and Forecast by Service Type
11.3. MEA Behavioral Health Market Size and Forecast by Disorder
11.4. MEA Behavioral Health Market Size and Forecast by End User
11.5. GCC Behavioral Health Market
11.6. South Africa Behavioral Health Market
11.7. Rest of MEA Behavioral Health Market
12. Companies in the Global Behavioral Health Market
12.1. Cerner
12.1.1. Company Snapshot
12.1.2. Company Overview
12.1.3. Financial Performance (2016-2020)
12.1.3.1. Net Revenue
12.1.3.2. Gross Profit
12.1.3.3. Geographical Revenue, 2020
12.1.4. Product Offerings
12.1.5. Recent Initiatives (2017-2020)
12.2. Netsmart
12.2.1. Company Snapshot
12.2.2. Company Overview
12.2.3. Financial Performance (2015-2020)
12.2.3.1. Net Revenue
12.2.3.2. Gross Profit
12.2.3.3. Geographical Revenue, 2020
12.2.4. Product Offerings
12.2.5. Recent Initiatives (2017-2020)
12.3. Core Solutions
12.3.1. Company Snapshot
12.3.2. Company Overview
12.3.3. Financial Performance (2015-2020)
12.3.3.1. Net Revenue
12.3.3.2. Gross Profit
12.3.3.3. Geographical Revenue, 2020
12.3.4. Product Offerings
12.3.5. Recent Initiatives (2017-2020)
12.4. Mindlinc
12.4.1. Company Snapshot
12.4.2. Company Overview
12.4.3. Financial Performance (2015-2020)
12.4.3.1. Net Revenue
12.4.3.2. Gross Profit
12.4.3.3. Geographical Revenue, 2020
12.4.4. Product Offerings
12.4.5. Recent Initiatives (2017-2020)
12.5. Nextgen Healthcare
12.5.1. Company Snapshot
12.5.2. Company Overview
12.5.3. Financial Performance (2015-2020)
12.5.3.1. Net Revenue
12.5.3.2. Gross Profit
12.5.3.3. Geographical Revenue, 2020
12.5.4. Product Offerings
12.5.5. Recent Initiatives (2017-2020)
12.6. The Echo Group
12.6.1. Company Snapshot
12.6.2. Company Overview
12.6.3. Financial Performance (2015-2020)
12.6.3.1. Net Revenue
12.6.3.2. Gross Profit
12.6.3.3. Geographical Revenue, 2020
12.6.4. Product Offerings
12.6.5. Recent Initiatives (2017-2020)
12.7. Valant
12.7.1. Company Snapshot
12.7.2. Company Overview
12.7.3. Financial Performance (2015-2020)
12.7.3.1. Net Revenue
12.7.3.2. Gross Profit
12.7.3.3. Geographical Revenue, 2020
12.7.4. Product Offerings
12.7.5. Recent Initiatives (2017-2020)
12.8. Welligent, Inc.
12.8.1. Company Snapshot
12.8.2. Company Overview
12.8.3. Financial Performance (2015-2020)
12.8.3.1. Net Revenue
12.8.3.2. Gross Profit
12.8.3.3. Geographical Revenue, 2020
12.8.4. Product Offerings
12.8.5. Recent Initiatives (2017-2020)
12.9. Qualifacts
12.9.1. Company Snapshot
12.9.2. Company Overview
12.9.3. Financial Performance (2015-2020)
12.9.3.1. Net Revenue
12.9.3.2. Gross Profit
12.9.3.3. Geographical Revenue, 2020
12.9.4. Product Offerings
12.9.5. Recent Initiatives (2017-2020)
12.10. Credible
12.10.1. Company Snapshot
12.10.2. Company Overview
12.10.3. Financial Performance (2015-2019)
12.10.3.1. Net Revenue
12.10.3.2. Gross Profit
12.10.3.3. Geographical Revenue, 2020
12.10.4. Product Offerings
12.10.5. Recent Initiatives (2017-2020)
12.11. Other Notable Players
13. Conclusion
14. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Behavioral Health Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Behavioral Health Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Behavioral Health Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Behavioral Health Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Behavioral Health Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Behavioral Health Market Drivers & Restraints 2021
Table 7. Behavioral Health Submarket Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Behavioral Health Submarket Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Behavioral Health Submarket Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Behavioral Health Submarket Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Behavioral Health Submarket Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Inpatient Hospital Treatment Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 13. Inpatient Hospital Treatment Submarket Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Inpatient Hospital Treatment Submarket Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Inpatient Hospital Treatment Submarket Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Inpatient Hospital Treatment Submarket Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Outpatient Counselling Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Outpatient Counselling Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Outpatient Counselling Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Outpatient Counselling Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Outpatient Counselling Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Home-Based Treatment Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Home-Based Treatment Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Home-Based Treatment Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Home-Based Treatment Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Home-Based Treatment Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Emergency Mental Health Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Emergency Mental Health Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Emergency Mental Health Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Emergency Mental Health Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Emergency Mental Health Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Intensive Care Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Intensive Care Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Intensive Care Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Intensive Care Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Intensive Care Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Behavioral Health Submarket Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 38. Behavioral Health Submarket Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Behavioral Health Submarket Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Behavioral Health Submarket Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Behavioral Health Submarket Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Anxiety Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Anxiety Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Anxiety Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Anxiety Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Anxiety Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Bipolar Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. Bipolar Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Bipolar Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Bipolar Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Bipolar Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Depression Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53. Depression Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Depression Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Depression Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Depression Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Eating Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58. Eating Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Eating Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Eating Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Eating Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Post-Traumatic Stress Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63. Post-Traumatic Stress Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Post-Traumatic Stress Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Post-Traumatic Stress Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Post-Traumatic Stress Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Substance Abuse Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68. Substance Abuse Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Substance Abuse Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Substance Abuse Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Substance Abuse Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Behavioral Health Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73. Behavioral Health Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Behavioral Health Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Behavioral Health Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Behavioral Health Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Outpatient Clinics Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 78. Outpatient Clinics Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Outpatient Clinics Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Outpatient Clinics Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Outpatient Clinics Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Rehabilitation Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 83. Rehabilitation Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Rehabilitation Clinics Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Rehabilitation Clinics Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Rehabilitation Clinics Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 87. Hospitals (Emergency) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 88. Hospitals (Emergency)Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Hospitals (Emergency)Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Hospitals (Emergency)Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Hospitals (Emergency)Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 92. Homecare Settings (Emergency) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 93. Homecare Settings (Emergency) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 94. Homecare Settings (Emergency) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 95. Homecare Settings (Emergency) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 96. Homecare Settings (Emergency) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 97. Regional Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 98. Regional Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 99. Regional Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 100. Regional Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 101. Regional Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 102. North America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 103. North America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 104. North America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 105. North America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 106. North America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 107. North America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 108. North America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 109. North America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 110. North America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 111. North America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 112. North America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 113. North America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 114. North America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 115. North America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 116. North America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 117. North America Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 118. North America Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 119. North America Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 120. North America Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 121. North America Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 122. US Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123. US Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124. US Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125. US Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126. US Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127. Canada Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128. Canada Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129. Canada Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130. Canada Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131. Canada Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132. Europe Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133. Europe Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134. Europe Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135. Europe Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136. Europe Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137. Europe Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138. Europe Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139. Europe Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140. Europe Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141. Europe Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142. Europe Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143. Europe Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144. Europe Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145. Europe Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146. Europe Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147. Europe Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148. Europe Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149. Europe Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150. Europe Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151. Europe Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152. UK Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153. UK Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154. UK Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155. UK Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156. UK Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157. Germany Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158. Germany Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159. Germany Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160. Germany Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161. Germany Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162. France Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163. France Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. France Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. France Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. France Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. Rest of Europe Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168. Rest of Europe Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. Rest of Europe Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. Rest of Europe Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. Rest of Europe Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. Asia Pacific Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173. Asia Pacific Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. Asia Pacific Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. Asia Pacific Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. Asia Pacific Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177. Asia Pacific Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. Asia Pacific Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. Asia Pacific Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. Asia Pacific Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. Asia Pacific Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. Asia Pacific Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183. Asia Pacific Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184. Asia Pacific Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185. Asia Pacific Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186. Asia Pacific Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187. Asia Pacific Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188. Asia Pacific Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189. Asia Pacific Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190. Asia Pacific Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191. Asia Pacific Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192. China Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193. China Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194. China Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195. China Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196. China Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197. India Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 198. India Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199. India Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200. India Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201. India Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202. Japan Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 203. Japan Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 204. Japan Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 205. Japan Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 206. Japan Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 207. Japan Military Aircraft Fleet (Aircraft Treatment type, Number of Aircraft)
Table 208. RoAPAC Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 209. RoAPAC Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 210. RoAPAC Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 211. RoAPAC Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 212. RoAPAC Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 213. Middle East Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 214. Middle East Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 215. Middle East Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 216. Middle East Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 217. Middle East Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 218. Middle East Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 219. Middle East Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 220. Middle East Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 221. Middle East Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 222. Middle East Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 223. Middle East Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 234. Middle East Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 235. Middle East Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 236. Middle East Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 237. Middle East Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 238. Latin America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 239. Latin America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 240. Latin America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 241. Latin America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 242. Latin America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 243. Latin America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 244. Latin America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 245. Latin America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 246. Latin America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 247. Latin America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 248. Latin America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 249. Latin America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 250. Latin America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 251. Latin America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 252. Latin America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 253. Africa Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 254. Africa Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 255. Africa Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 256. Africa Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 257. Africa Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 258. Africa Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 259. Africa Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 260. Africa Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 261. Africa Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 262. Africa Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 263. Leading 10 Behavioral Health Market Companies (Ranking, Company, Latest Total Company Sales US$M, HQ)
Table 264. Cerner Profile 2020 (CEO, HQ, Founded, Website)
Table 265. Cerner Behavioral Health Recent Developments
Table 266. Cerner Behavioral Health Product Offering (Segment, Product Offerings)
Table 267. Netsmart Profile 2020 (CEO, HQ, Founded, Website)
Table 268. Netsmart Behavioral Health Product Offering (Segment, Product Offerings)
Table 269. Core Solutions Profile 2020 (CEO, HQ, Founded, Website)
Table 270. Core Solutions Behavioral Health Recent Developments
Table 271. Core Solutions Behavioral Health Product Offering (Segment, Product Offerings)
Table 272. Mindlinc Profile 2020 (CEO, HQ, Founded, Website)
Table 273. Mindlinc Behavioral Health Recent Developments
Table 274. Mindlinc Behavioral Health Product Offering (Segment, Product Offerings)
Table 275. Nextgen Healthcare Profile 2020 (CEO, HQ, Founded, Website)
Table 276. Nextgen Healthcare Behavioral Health Product Offering (Segment, Product Offerings)
Table 277. The Echo Group Company Profile 2020 (CEO, HQ, Founded, Website)
Table 278. The Echo Group Company Optic Network Recent Developments
Table 279. The Echo Group Behavioral Health Product Offering (Segment, Product Offerings)
Table 280. Valant Profile 2020 (CEO, HQ, Founded, Website)
Table 281. Valant Behavioral Health Product Offering (Segment, Product Offerings)
Table 282. Welligent Profile 2020 (CEO, HQ, Founded, Website)
Table 283. Welligent Behavioral Health Product Offering (Segment, Product Offerings)
Table 284. Qualifacts Profile 2020 (CEO, HQ, Founded, Website)
Table 285. Qualifacts Behavioral Health Product Offering (Segment, Product Offerings)
Table 286. Credible Profile 2020 (CEO, Total Company Sales US$M, HQ, Founded, No. of Employees, Ticker, Website)
Table 287. Credible Total Company Sales 2015-2020 (US$M, AGR %)
Table 288. Credible Sales by Segment of Business 2019 (US$M)
Table 289. Kareo Sales by Regional Segment of Business 2019 (US$M)
Table 290. Kareo Behavioral Health Product Offering (Segment, Product Offerings)
Table 291. Other Companies Involved in the Behavioral Health Market 2020 (Company, Location)
LIST OF FIGURES
Figure 1. Behavioral Health Market Service Type Overview
Figure 2. Behavioral Health Market Disorder Overview
Figure 3. Behavioral Health Market End User Overview
Figure 4. Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 5. Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 6. Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 7. Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 8. Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 9. Behavioral Health Submarket Forecast by Service Type 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 10. Behavioral Health Submarket Forecast by Service Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 11. Behavioral Health Submarket Forecast by Service Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 12. Behavioral Health Submarket Forecast by Service Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 13. Behavioral Health Submarket Forecast by Service Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 14. Inpatient Hospital Treatment Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 15. Inpatient Hospital Treatment Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 16. Inpatient Hospital Treatment Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 17. Inpatient Hospital Treatment Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 18. Inpatient Hospital Treatment Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 19. Outpatient Counselling Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 20. Outpatient Counselling Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 21. Outpatient Counselling Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 22. Outpatient Counselling Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 23. Outpatient Counselling Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 24. Home-Based Treatment Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 25. Home-Based Treatment Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 26. Home-Based Treatment Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario U)
Figure 27. Home-Based Treatment Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario W)
Figure 28. Home-Based Treatment Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario L)
Figure 29. Emergency Mental Health Services Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 30. Emergency Mental Health Services Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 31. Emergency Mental Health Services Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario U)
Figure 32. Emergency Mental Health Services Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario W)
Figure 33. Emergency Mental Health Services Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario L)
Figure 34. Intensive Care Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 35. Intensive Care Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 36. Intensive Care Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario U)
Figure 37. Intensive Care Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario W)
Figure 38. Intensive Care Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario L)
Figure 39. Behavioral Health Submarket Forecast by Disorder 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 40. Behavioral Health Submarket Forecast by Disorder 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 41. Behavioral Health Submarket Forecast by Disorder 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 42. Behavioral Health Submarket Forecast by Disorder 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 43. Behavioral Health Submarket Forecast by Disorder 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 44. Anxiety Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 45. Anxiety Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 46. Anxiety Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 47. Anxiety Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 48. Anxiety Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 49. Bipolar Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 50. Bipolar Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 51. Bipolar Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 52. Bipolar Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 53. Bipolar Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 54. Depression Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 55. Depression Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 56. Depression Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 57. Depression Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 58. Depression Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 59. Eating Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 60. Eating Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 61. Eating Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 62. Eating Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 63. Eating Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 64. Post-Traumatic Stress Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 65. Post-Traumatic Stress Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 66. Post-Traumatic Stress Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 67. Post-Traumatic Stress Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 68. Post-Traumatic Stress Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 69. Substance Abuse Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 70. Substance Abuse Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 71. Substance Abuse Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 72. Substance Abuse Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 73. Substance Abuse Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 74. Behavioral Health Submarket Forecast by End User 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 75. Behavioral Health Submarket Forecast by End User 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 76. Behavioral Health Submarket Forecast by End User 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 77. Behavioral Health Submarket Forecast by End User 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 78. Behavioral Health Submarket Forecast by End User 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 79. Regional Behavioral Health Market Forecast 2021-2031 (Sales US$M, Global AGR %)
Figure 80. Regional Behavioral Health Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario V)
Figure 81. Regional Behavioral Health Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario U)
Figure 82. Regional Behavioral Health Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario W)
Figure 83. Regional Behavioral Health Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario L)
Figure 84. North America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %) (Before COVID)
Figure 85. North America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 86. North America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 87. North America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 88. North America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 89. North America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %) (Before COVID)
Figure 90. North America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 91. North America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 92. North America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 93. North America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 94. North America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %) (Before COVID)
Figure 95. North America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 96. North America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 97. North America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 98. North America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 99. North America Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 100. North America Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 101. North America Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 102. North America Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 103. North America Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 104. US Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 105. US Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 106. US Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 107. US Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 108. US Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 109. Canada Behavioral Health Market Forecast 2021-2031 (US$M, AGR %)
Figure 110. Canada Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 111. Canada Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 112. Canada Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 113. Canada Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 114. Europe Behavioral Health Market Forecast by Service Type 2021-2031 (US$M)
Figure 115. Europe Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 116. Europe Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 117. Europe Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 118. Europe Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 119. Europe Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (Before COVID)
Figure 120. Europe Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario V)
Figure 121. Europe Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario U)
Figure 122. Europe Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario W)
Figure 123. Europe Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario L)
Figure 124. Europe Behavioral Health Market Forecast by End User 2021-2031 (US$M) (Before COVID)
Figure 125. Europe Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 126. Europe Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 127. Europe Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 128. Europe Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 129. Europe Behavioral Health Market Forecast by Country 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 130. Europe Behavioral Health Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 131. Europe Behavioral Health Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 132. Europe Behavioral Health Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 133. Europe Behavioral Health Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 134. UK Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 135. UK Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 136. UK Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID – Scenario U)
Figure 137. UK Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 138. UK Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 139. Germany Behavioral Health Market Forecast 2021-2031 (US$M, AGR %)
Figure 140. Germany Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 141. Germany Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 142. Germany Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 143. Germany Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 144. France Behavioral Health Market Forecast 2021-2031 (US$M, AGR %)
Figure 145. France Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 146. France Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 147. France Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 148. France Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 149. Rest of Europe Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 150. Rest of Europe Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 151. Rest of Europe Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 152. Rest of Europe Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 153. Rest of Europe Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 154. Asia-Pacific Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (Before COVID)
Figure 155. Asia-Pacific Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 156. Asia-Pacific Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 157. Asia-Pacific Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 158. Asia-Pacific Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 159. Asia-Pacific Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (Before COVID)
Figure 160. Asia-Pacific Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario V)
Figure 161. Asia-Pacific Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario U)
Figure 162. Asia-Pacific Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario W)
Figure 163. Asia-Pacific Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario L)
Figure 164. Asia-Pacific Behavioral Health Market Forecast by End User 2021-2031 (US$M) (Before COVID)
Figure 165. Asia-Pacific Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 166. Asia-Pacific Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 167. Asia-Pacific Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 168. Asia-Pacific Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 169. Asia-Pacific Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 170. Asia-Pacific Behavioral Health Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 171. Asia-Pacific Behavioral Health Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 172. Asia-Pacific Behavioral Health Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 173. Asia-Pacific Behavioral Health Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 174. China Behavioral Health Market Forecast 2021-2031 (US$M, AGR %)
Figure 175. China Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 176. China Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 177. China Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 178. China Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 179. India Behavioral Health Market Forecast 2021-2031 (US$M, AGR %)
Figure 180. India Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 181. India Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 182. India Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 183. India Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 184. Japan Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 185. Japan Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 186. Japan Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 187. Japan Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 188. Japan Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 189. Rest of APAC Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 190. Rest of APAC Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 191. Rest of APAC Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 192. Rest of APAC Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 193. Rest of APAC Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 194. Middle East Behavioral Health Market Forecast by Service Type 2021-2031 (US$M)
Figure 195. Middle East Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 196. Middle East Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 197. Middle East Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 198. Middle East Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 199. Middle East Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (Before COVID)
Figure 200. Middle East Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario V)
Figure 201. Middle East Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario U)
Figure 202. Middle East Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario W)
Figure 203. Middle East Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario L)
Figure 204. Middle East Behavioral Health Market Forecast by End User 2021-2031 (US$M) (Before COVID)
Figure 205. Middle East Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 206. Middle East Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 207. Middle East Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 208. Middle East Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 209. Latin America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M)
Figure 210. Latin America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 211. Latin America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 212. Latin America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 213. Latin America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 214. Latin America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (Before COVID)
Figure 215. Latin America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario V)
Figure 216. Latin America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario U)
Figure 217. Latin America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario W)
Figure 218. Latin America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario L)
Figure 219. Latin America Behavioral Health Market Forecast by End User 2021-2031 (US$M) (Before COVID)
Figure 220. Latin America Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 221. Latin America Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 222. Latin America Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 223. Latin America Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 224. Africa Behavioral Health Market Forecast by Service Type 2021-2031 (US$M)
Figure 225. Africa Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 226. Africa Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 227. Africa Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 228. Africa Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 229. Africa Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (Before COVID)
Figure 230. Africa Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario V)
Figure 231. Africa Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario U)
Figure 232. Africa Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario W)
Figure 233. Africa Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario L)
Figure 234. Africa Behavioral Health Market Forecast by End User 2021-2031 (US$M) (Before COVID)
Figure 235. Africa Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 236. Africa Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 237. Africa Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 238. Africa Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 239. Porter’s Five Force Analysis
Companies Mentioned
1. Cerner
2. Netsmart
3. Core Solutions
4. Mindlinc
5. Nextgen Healthcare
6. The Echo Group
7. Valant
8. Welligent
9. Qualifacts
10. Credible
11. Meditab
12. Kareo
13. Compulink
14. Advance Data Systems
15. Advancedmd, Inc.
16. Abbott Laboratories Inc.
17. Alkermes PLC
18. AstraZeneca Plc
19. Azumio Inc.
20. Bausch Health Companies, Inc.
21. Beijing PINS Medical Co.
22. BioControl Medical
23. Brainsway
24. Bristol-Myers Squibb Co.
25. Caeden, Inc.
26. Darta Systems
27. Electromedical Products International Inc.
28. Eli Lilly and Company
29. F. Hoffmann-La Roche AG
30. Fisher Wallace Laboratories, Inc.
31. GlaxoSmithKline PLC
32. H. Lundbeck A/S
33. Headspace, Inc.
34. Johnson & Johnson Services, Inc.
35. Lief Therapeutics
36. Lupin Pharmaceuticals, Inc.
37. MAG & More GmbH
38. MagVenture, Inc.
39. Merck & Co., Inc.
40. Mood Tracker Web Media, LLC
41. Mylan N.V
42. Neuronetics, Inc.
43. NeuroSigma, Inc.
44. Neuvana, LLC
45. Allergan PLC
46. Otsuka Pharmaceutical Co., Ltd.
47. Personal Zen
48. Prana Tech LLC
49. Sanvello Health, Inc.
50. Spire, Inc.
51. Takeda Pharmaceutical Co. Ltd.
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. What is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Global Behavioral Health Market
2.1. Behavioral Health Market Definition
2.2. Service Type Submarkets Definitions
2.3. Disorder Submarkets Definitions
2.4. End User Submarkets Definitions
3. Global Behavioral Health Market Overview
3.1. Global Behavioral Health Market Size and Forecast by Region
3.2. Global Behavioral Health Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Rising Mental Disorders Around the Globe
3.3.1.2. Increasing Awareness for Behavioral Health
3.3.1.3. Cohesive Reimbursement Policies
3.3.1.4. Increasing Investment in R&D
3.3.2. Market Restraints/Challenges
3.3.2.1. High Cost of treatment
3.3.2.2. Side Effects Associated with the Treatment
3.3.3. Opportunities
3.3.3.1. Healthcare Reforms in Emerging Economies
3.3.3.2. Technological Advancement and Innovation
3.3.3.3. Rising New Entrants
4. Global Behavioral Health Market Analysis and Forecast 2021-2031, by Service Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Inpatient Hospital Treatment
4.1.1.1. New Development in Therapies
4.1.2. Outpatient Counselling
4.1.2.1. Increasingly Adopted Around the Globe
4.1.3. Home-Based Treatment Services
4.1.3.1. Considerable Success Rate
4.1.4. Others
5. Global Behavioral Health Market Analysis and Forecast, 2021-2031 by Disorder (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Anxiety Disorder
5.1.1.1. Increasing work pressure at office
5.1.2. Bipolar Disorder
5.1.2.1. Rising mental stress
5.1.3. Depression
5.1.3.1. Unfavorable lifestyle changes and mental stress
5.1.4. Eating Disorder
5.1.4.1. Unhealthy lifestyle
5.1.5. Post-Traumatic Stress Disorder
5.1.5.1. Rising accidents and tragedies
5.1.6. Substance Abuse Disorder
5.1.6.1. Youths are inclined towards drugs and substance abuse
6. Global Behavioral Health Market Analysis and Forecast, 2021-2031 by End User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Outpatient Clinics
6.1.2. Rehabilitation Centers
6.1.3. Hospitals (Emergency)
6.1.4. Homecare Settings
7. North America Behavioral Health Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. North America Behavioral Health Market Size and Forecast by Service Type
7.3. North America Behavioral Health Market Size and Forecast by Disorder
7.4. North America Behavioral Health Market Size and Forecast by End User
7.5. U.S. Behavioral Health Market
7.5.1. Rising Adoption of Stress Relieving Therapies and Applications
7.6. Canada Behavioral Health Market
7.6.1. Rising Incidence and Prevalence of Depression and Mental Disorders
8. Europe Behavioral Health Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Europe Behavioral Health Market Size and Forecast by Service Type
8.3. Europe Behavioral Health Market Size and Forecast by Disorder
8.4. Europe Behavioral Health Market Size and Forecast by End User
8.5. UK Behavioral Health Market
8.6. Germany Behavioral Health Market
8.7. France Behavioral Health Market
8.8. Rest of Europe Behavioral Health Market
9. Asia Pacific Behavioral Health Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Asia Pacific Behavioral Health Market Size and Forecast by Service type
9.3. Asia Pacific Behavioral Health Market Size and Forecast by Disorder
9.4. Asia Pacific Behavioral Health Market Size and Forecast by End User
9.5. China Behavioral Health Market
9.6. India Behavioral Health Market
9.7. Japan Behavioral Health Market
9.8. Rest of Asia Pacific Behavioral Health Market
10. Latin America Behavioral Health Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Latin America Behavioral Health Market Size and Forecast by Service type
10.3. Latin America Behavioral Health Market Size and Forecast by Disorder
10.4. Latin America Behavioral Health Market Size and Forecast by End User
10.4.1. Brazil Behavioral Health Market
10.4.2. Mexico Behavioral Health Market
10.4.3. Rest of Latin America Behavioral Health Market
11. MEA Behavioral Health Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. MEA Behavioral Health Market Size and Forecast by Service Type
11.3. MEA Behavioral Health Market Size and Forecast by Disorder
11.4. MEA Behavioral Health Market Size and Forecast by End User
11.5. GCC Behavioral Health Market
11.6. South Africa Behavioral Health Market
11.7. Rest of MEA Behavioral Health Market
12. Companies in the Global Behavioral Health Market
12.1. Cerner
12.1.1. Company Snapshot
12.1.2. Company Overview
12.1.3. Financial Performance (2016-2020)
12.1.3.1. Net Revenue
12.1.3.2. Gross Profit
12.1.3.3. Geographical Revenue, 2020
12.1.4. Product Offerings
12.1.5. Recent Initiatives (2017-2020)
12.2. Netsmart
12.2.1. Company Snapshot
12.2.2. Company Overview
12.2.3. Financial Performance (2015-2020)
12.2.3.1. Net Revenue
12.2.3.2. Gross Profit
12.2.3.3. Geographical Revenue, 2020
12.2.4. Product Offerings
12.2.5. Recent Initiatives (2017-2020)
12.3. Core Solutions
12.3.1. Company Snapshot
12.3.2. Company Overview
12.3.3. Financial Performance (2015-2020)
12.3.3.1. Net Revenue
12.3.3.2. Gross Profit
12.3.3.3. Geographical Revenue, 2020
12.3.4. Product Offerings
12.3.5. Recent Initiatives (2017-2020)
12.4. Mindlinc
12.4.1. Company Snapshot
12.4.2. Company Overview
12.4.3. Financial Performance (2015-2020)
12.4.3.1. Net Revenue
12.4.3.2. Gross Profit
12.4.3.3. Geographical Revenue, 2020
12.4.4. Product Offerings
12.4.5. Recent Initiatives (2017-2020)
12.5. Nextgen Healthcare
12.5.1. Company Snapshot
12.5.2. Company Overview
12.5.3. Financial Performance (2015-2020)
12.5.3.1. Net Revenue
12.5.3.2. Gross Profit
12.5.3.3. Geographical Revenue, 2020
12.5.4. Product Offerings
12.5.5. Recent Initiatives (2017-2020)
12.6. The Echo Group
12.6.1. Company Snapshot
12.6.2. Company Overview
12.6.3. Financial Performance (2015-2020)
12.6.3.1. Net Revenue
12.6.3.2. Gross Profit
12.6.3.3. Geographical Revenue, 2020
12.6.4. Product Offerings
12.6.5. Recent Initiatives (2017-2020)
12.7. Valant
12.7.1. Company Snapshot
12.7.2. Company Overview
12.7.3. Financial Performance (2015-2020)
12.7.3.1. Net Revenue
12.7.3.2. Gross Profit
12.7.3.3. Geographical Revenue, 2020
12.7.4. Product Offerings
12.7.5. Recent Initiatives (2017-2020)
12.8. Welligent, Inc.
12.8.1. Company Snapshot
12.8.2. Company Overview
12.8.3. Financial Performance (2015-2020)
12.8.3.1. Net Revenue
12.8.3.2. Gross Profit
12.8.3.3. Geographical Revenue, 2020
12.8.4. Product Offerings
12.8.5. Recent Initiatives (2017-2020)
12.9. Qualifacts
12.9.1. Company Snapshot
12.9.2. Company Overview
12.9.3. Financial Performance (2015-2020)
12.9.3.1. Net Revenue
12.9.3.2. Gross Profit
12.9.3.3. Geographical Revenue, 2020
12.9.4. Product Offerings
12.9.5. Recent Initiatives (2017-2020)
12.10. Credible
12.10.1. Company Snapshot
12.10.2. Company Overview
12.10.3. Financial Performance (2015-2019)
12.10.3.1. Net Revenue
12.10.3.2. Gross Profit
12.10.3.3. Geographical Revenue, 2020
12.10.4. Product Offerings
12.10.5. Recent Initiatives (2017-2020)
12.11. Other Notable Players
13. Conclusion
14. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Behavioral Health Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Behavioral Health Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Behavioral Health Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Behavioral Health Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Behavioral Health Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Behavioral Health Market Drivers & Restraints 2021
Table 7. Behavioral Health Submarket Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Behavioral Health Submarket Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Behavioral Health Submarket Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Behavioral Health Submarket Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Behavioral Health Submarket Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Inpatient Hospital Treatment Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 13. Inpatient Hospital Treatment Submarket Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Inpatient Hospital Treatment Submarket Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Inpatient Hospital Treatment Submarket Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Inpatient Hospital Treatment Submarket Forecast by Treatment Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Outpatient Counselling Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Outpatient Counselling Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Outpatient Counselling Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Outpatient Counselling Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Outpatient Counselling Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Home-Based Treatment Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Home-Based Treatment Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Home-Based Treatment Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Home-Based Treatment Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Home-Based Treatment Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Emergency Mental Health Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Emergency Mental Health Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Emergency Mental Health Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Emergency Mental Health Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Emergency Mental Health Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Intensive Care Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Intensive Care Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Intensive Care Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Intensive Care Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Intensive Care Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Behavioral Health Submarket Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 38. Behavioral Health Submarket Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Behavioral Health Submarket Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Behavioral Health Submarket Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Behavioral Health Submarket Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Anxiety Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Anxiety Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Anxiety Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Anxiety Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Anxiety Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Bipolar Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. Bipolar Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Bipolar Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Bipolar Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Bipolar Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Depression Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53. Depression Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Depression Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Depression Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Depression Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Eating Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58. Eating Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Eating Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Eating Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Eating Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Post-Traumatic Stress Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63. Post-Traumatic Stress Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Post-Traumatic Stress Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Post-Traumatic Stress Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Post-Traumatic Stress Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Substance Abuse Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68. Substance Abuse Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Substance Abuse Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Substance Abuse Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Substance Abuse Disorder Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Behavioral Health Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73. Behavioral Health Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Behavioral Health Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Behavioral Health Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Behavioral Health Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Outpatient Clinics Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 78. Outpatient Clinics Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Outpatient Clinics Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Outpatient Clinics Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Outpatient Clinics Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Rehabilitation Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 83. Rehabilitation Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Rehabilitation Clinics Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Rehabilitation Clinics Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Rehabilitation Clinics Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 87. Hospitals (Emergency) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 88. Hospitals (Emergency)Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Hospitals (Emergency)Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Hospitals (Emergency)Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Hospitals (Emergency)Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 92. Homecare Settings (Emergency) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 93. Homecare Settings (Emergency) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 94. Homecare Settings (Emergency) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 95. Homecare Settings (Emergency) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 96. Homecare Settings (Emergency) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 97. Regional Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 98. Regional Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 99. Regional Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 100. Regional Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 101. Regional Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 102. North America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 103. North America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 104. North America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 105. North America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 106. North America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 107. North America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 108. North America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 109. North America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 110. North America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 111. North America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 112. North America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 113. North America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 114. North America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 115. North America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 116. North America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 117. North America Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 118. North America Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 119. North America Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 120. North America Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 121. North America Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 122. US Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123. US Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124. US Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125. US Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126. US Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127. Canada Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128. Canada Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129. Canada Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130. Canada Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131. Canada Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132. Europe Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133. Europe Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134. Europe Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135. Europe Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136. Europe Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137. Europe Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138. Europe Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139. Europe Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140. Europe Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141. Europe Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142. Europe Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143. Europe Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144. Europe Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145. Europe Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146. Europe Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147. Europe Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148. Europe Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149. Europe Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150. Europe Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151. Europe Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152. UK Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153. UK Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154. UK Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155. UK Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156. UK Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157. Germany Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158. Germany Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159. Germany Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160. Germany Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161. Germany Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162. France Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163. France Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. France Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. France Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. France Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. Rest of Europe Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168. Rest of Europe Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. Rest of Europe Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. Rest of Europe Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. Rest of Europe Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. Asia Pacific Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173. Asia Pacific Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. Asia Pacific Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. Asia Pacific Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. Asia Pacific Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177. Asia Pacific Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. Asia Pacific Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. Asia Pacific Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. Asia Pacific Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. Asia Pacific Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. Asia Pacific Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183. Asia Pacific Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184. Asia Pacific Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185. Asia Pacific Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186. Asia Pacific Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187. Asia Pacific Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188. Asia Pacific Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189. Asia Pacific Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190. Asia Pacific Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191. Asia Pacific Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192. China Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193. China Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194. China Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195. China Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196. China Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197. India Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 198. India Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199. India Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200. India Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201. India Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202. Japan Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 203. Japan Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 204. Japan Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 205. Japan Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 206. Japan Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 207. Japan Military Aircraft Fleet (Aircraft Treatment type, Number of Aircraft)
Table 208. RoAPAC Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 209. RoAPAC Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 210. RoAPAC Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 211. RoAPAC Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 212. RoAPAC Behavioral Health Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 213. Middle East Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 214. Middle East Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 215. Middle East Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 216. Middle East Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 217. Middle East Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 218. Middle East Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 219. Middle East Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 220. Middle East Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 221. Middle East Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 222. Middle East Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 223. Middle East Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 234. Middle East Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 235. Middle East Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 236. Middle East Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 237. Middle East Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 238. Latin America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 239. Latin America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 240. Latin America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 241. Latin America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 242. Latin America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 243. Latin America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 244. Latin America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 245. Latin America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 246. Latin America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 247. Latin America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 248. Latin America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 249. Latin America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 250. Latin America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 251. Latin America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 252. Latin America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 253. Africa Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 254. Africa Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 255. Africa Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 256. Africa Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 257. Africa Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 258. Africa Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 259. Africa Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 260. Africa Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 261. Africa Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 262. Africa Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 263. Leading 10 Behavioral Health Market Companies (Ranking, Company, Latest Total Company Sales US$M, HQ)
Table 264. Cerner Profile 2020 (CEO, HQ, Founded, Website)
Table 265. Cerner Behavioral Health Recent Developments
Table 266. Cerner Behavioral Health Product Offering (Segment, Product Offerings)
Table 267. Netsmart Profile 2020 (CEO, HQ, Founded, Website)
Table 268. Netsmart Behavioral Health Product Offering (Segment, Product Offerings)
Table 269. Core Solutions Profile 2020 (CEO, HQ, Founded, Website)
Table 270. Core Solutions Behavioral Health Recent Developments
Table 271. Core Solutions Behavioral Health Product Offering (Segment, Product Offerings)
Table 272. Mindlinc Profile 2020 (CEO, HQ, Founded, Website)
Table 273. Mindlinc Behavioral Health Recent Developments
Table 274. Mindlinc Behavioral Health Product Offering (Segment, Product Offerings)
Table 275. Nextgen Healthcare Profile 2020 (CEO, HQ, Founded, Website)
Table 276. Nextgen Healthcare Behavioral Health Product Offering (Segment, Product Offerings)
Table 277. The Echo Group Company Profile 2020 (CEO, HQ, Founded, Website)
Table 278. The Echo Group Company Optic Network Recent Developments
Table 279. The Echo Group Behavioral Health Product Offering (Segment, Product Offerings)
Table 280. Valant Profile 2020 (CEO, HQ, Founded, Website)
Table 281. Valant Behavioral Health Product Offering (Segment, Product Offerings)
Table 282. Welligent Profile 2020 (CEO, HQ, Founded, Website)
Table 283. Welligent Behavioral Health Product Offering (Segment, Product Offerings)
Table 284. Qualifacts Profile 2020 (CEO, HQ, Founded, Website)
Table 285. Qualifacts Behavioral Health Product Offering (Segment, Product Offerings)
Table 286. Credible Profile 2020 (CEO, Total Company Sales US$M, HQ, Founded, No. of Employees, Ticker, Website)
Table 287. Credible Total Company Sales 2015-2020 (US$M, AGR %)
Table 288. Credible Sales by Segment of Business 2019 (US$M)
Table 289. Kareo Sales by Regional Segment of Business 2019 (US$M)
Table 290. Kareo Behavioral Health Product Offering (Segment, Product Offerings)
Table 291. Other Companies Involved in the Behavioral Health Market 2020 (Company, Location)
LIST OF FIGURES
Figure 1. Behavioral Health Market Service Type Overview
Figure 2. Behavioral Health Market Disorder Overview
Figure 3. Behavioral Health Market End User Overview
Figure 4. Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 5. Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 6. Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 7. Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 8. Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 9. Behavioral Health Submarket Forecast by Service Type 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 10. Behavioral Health Submarket Forecast by Service Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 11. Behavioral Health Submarket Forecast by Service Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 12. Behavioral Health Submarket Forecast by Service Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 13. Behavioral Health Submarket Forecast by Service Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 14. Inpatient Hospital Treatment Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 15. Inpatient Hospital Treatment Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 16. Inpatient Hospital Treatment Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 17. Inpatient Hospital Treatment Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 18. Inpatient Hospital Treatment Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 19. Outpatient Counselling Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 20. Outpatient Counselling Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 21. Outpatient Counselling Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 22. Outpatient Counselling Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 23. Outpatient Counselling Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 24. Home-Based Treatment Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 25. Home-Based Treatment Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 26. Home-Based Treatment Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario U)
Figure 27. Home-Based Treatment Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario W)
Figure 28. Home-Based Treatment Services Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario L)
Figure 29. Emergency Mental Health Services Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 30. Emergency Mental Health Services Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 31. Emergency Mental Health Services Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario U)
Figure 32. Emergency Mental Health Services Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario W)
Figure 33. Emergency Mental Health Services Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario L)
Figure 34. Intensive Care Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 35. Intensive Care Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 36. Intensive Care Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario U)
Figure 37. Intensive Care Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario W)
Figure 38. Intensive Care Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario L)
Figure 39. Behavioral Health Submarket Forecast by Disorder 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 40. Behavioral Health Submarket Forecast by Disorder 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 41. Behavioral Health Submarket Forecast by Disorder 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 42. Behavioral Health Submarket Forecast by Disorder 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 43. Behavioral Health Submarket Forecast by Disorder 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 44. Anxiety Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 45. Anxiety Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 46. Anxiety Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 47. Anxiety Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 48. Anxiety Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 49. Bipolar Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 50. Bipolar Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 51. Bipolar Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 52. Bipolar Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 53. Bipolar Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 54. Depression Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 55. Depression Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 56. Depression Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 57. Depression Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 58. Depression Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 59. Eating Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 60. Eating Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 61. Eating Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 62. Eating Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 63. Eating Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 64. Post-Traumatic Stress Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 65. Post-Traumatic Stress Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 66. Post-Traumatic Stress Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 67. Post-Traumatic Stress Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 68. Post-Traumatic Stress Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 69. Substance Abuse Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 70. Substance Abuse Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 71. Substance Abuse Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 72. Substance Abuse Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 73. Substance Abuse Disorder Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 74. Behavioral Health Submarket Forecast by End User 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 75. Behavioral Health Submarket Forecast by End User 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 76. Behavioral Health Submarket Forecast by End User 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 77. Behavioral Health Submarket Forecast by End User 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 78. Behavioral Health Submarket Forecast by End User 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 79. Regional Behavioral Health Market Forecast 2021-2031 (Sales US$M, Global AGR %)
Figure 80. Regional Behavioral Health Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario V)
Figure 81. Regional Behavioral Health Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario U)
Figure 82. Regional Behavioral Health Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario W)
Figure 83. Regional Behavioral Health Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario L)
Figure 84. North America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %) (Before COVID)
Figure 85. North America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 86. North America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 87. North America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 88. North America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 89. North America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %) (Before COVID)
Figure 90. North America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 91. North America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 92. North America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 93. North America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 94. North America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %) (Before COVID)
Figure 95. North America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 96. North America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 97. North America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 98. North America Behavioral Health Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 99. North America Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 100. North America Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 101. North America Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 102. North America Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 103. North America Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 104. US Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 105. US Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 106. US Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 107. US Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 108. US Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 109. Canada Behavioral Health Market Forecast 2021-2031 (US$M, AGR %)
Figure 110. Canada Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 111. Canada Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 112. Canada Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 113. Canada Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 114. Europe Behavioral Health Market Forecast by Service Type 2021-2031 (US$M)
Figure 115. Europe Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 116. Europe Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 117. Europe Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 118. Europe Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 119. Europe Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (Before COVID)
Figure 120. Europe Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario V)
Figure 121. Europe Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario U)
Figure 122. Europe Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario W)
Figure 123. Europe Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario L)
Figure 124. Europe Behavioral Health Market Forecast by End User 2021-2031 (US$M) (Before COVID)
Figure 125. Europe Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 126. Europe Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 127. Europe Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 128. Europe Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 129. Europe Behavioral Health Market Forecast by Country 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 130. Europe Behavioral Health Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 131. Europe Behavioral Health Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 132. Europe Behavioral Health Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 133. Europe Behavioral Health Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 134. UK Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 135. UK Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 136. UK Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID – Scenario U)
Figure 137. UK Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 138. UK Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 139. Germany Behavioral Health Market Forecast 2021-2031 (US$M, AGR %)
Figure 140. Germany Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 141. Germany Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 142. Germany Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 143. Germany Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 144. France Behavioral Health Market Forecast 2021-2031 (US$M, AGR %)
Figure 145. France Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 146. France Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 147. France Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 148. France Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 149. Rest of Europe Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 150. Rest of Europe Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 151. Rest of Europe Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 152. Rest of Europe Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 153. Rest of Europe Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 154. Asia-Pacific Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (Before COVID)
Figure 155. Asia-Pacific Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 156. Asia-Pacific Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 157. Asia-Pacific Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 158. Asia-Pacific Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 159. Asia-Pacific Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (Before COVID)
Figure 160. Asia-Pacific Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario V)
Figure 161. Asia-Pacific Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario U)
Figure 162. Asia-Pacific Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario W)
Figure 163. Asia-Pacific Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario L)
Figure 164. Asia-Pacific Behavioral Health Market Forecast by End User 2021-2031 (US$M) (Before COVID)
Figure 165. Asia-Pacific Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 166. Asia-Pacific Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 167. Asia-Pacific Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 168. Asia-Pacific Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 169. Asia-Pacific Behavioral Health Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 170. Asia-Pacific Behavioral Health Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 171. Asia-Pacific Behavioral Health Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 172. Asia-Pacific Behavioral Health Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 173. Asia-Pacific Behavioral Health Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 174. China Behavioral Health Market Forecast 2021-2031 (US$M, AGR %)
Figure 175. China Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 176. China Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 177. China Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 178. China Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 179. India Behavioral Health Market Forecast 2021-2031 (US$M, AGR %)
Figure 180. India Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 181. India Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 182. India Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 183. India Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 184. Japan Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 185. Japan Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 186. Japan Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 187. Japan Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 188. Japan Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 189. Rest of APAC Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 190. Rest of APAC Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 191. Rest of APAC Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 192. Rest of APAC Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 193. Rest of APAC Behavioral Health Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 194. Middle East Behavioral Health Market Forecast by Service Type 2021-2031 (US$M)
Figure 195. Middle East Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 196. Middle East Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 197. Middle East Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 198. Middle East Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 199. Middle East Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (Before COVID)
Figure 200. Middle East Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario V)
Figure 201. Middle East Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario U)
Figure 202. Middle East Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario W)
Figure 203. Middle East Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario L)
Figure 204. Middle East Behavioral Health Market Forecast by End User 2021-2031 (US$M) (Before COVID)
Figure 205. Middle East Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 206. Middle East Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 207. Middle East Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 208. Middle East Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 209. Latin America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M)
Figure 210. Latin America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 211. Latin America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 212. Latin America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 213. Latin America Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 214. Latin America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (Before COVID)
Figure 215. Latin America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario V)
Figure 216. Latin America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario U)
Figure 217. Latin America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario W)
Figure 218. Latin America Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario L)
Figure 219. Latin America Behavioral Health Market Forecast by End User 2021-2031 (US$M) (Before COVID)
Figure 220. Latin America Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 221. Latin America Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 222. Latin America Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 223. Latin America Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 224. Africa Behavioral Health Market Forecast by Service Type 2021-2031 (US$M)
Figure 225. Africa Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 226. Africa Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 227. Africa Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 228. Africa Behavioral Health Market Forecast by Service Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 229. Africa Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (Before COVID)
Figure 230. Africa Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario V)
Figure 231. Africa Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario U)
Figure 232. Africa Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario W)
Figure 233. Africa Behavioral Health Market Forecast by Disorder 2021-2031 (US$M) (COVID - Scenario L)
Figure 234. Africa Behavioral Health Market Forecast by End User 2021-2031 (US$M) (Before COVID)
Figure 235. Africa Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 236. Africa Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 237. Africa Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 238. Africa Behavioral Health Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 239. Porter’s Five Force Analysis
Companies Mentioned
1. Cerner
2. Netsmart
3. Core Solutions
4. Mindlinc
5. Nextgen Healthcare
6. The Echo Group
7. Valant
8. Welligent
9. Qualifacts
10. Credible
11. Meditab
12. Kareo
13. Compulink
14. Advance Data Systems
15. Advancedmd, Inc.
16. Abbott Laboratories Inc.
17. Alkermes PLC
18. AstraZeneca Plc
19. Azumio Inc.
20. Bausch Health Companies, Inc.
21. Beijing PINS Medical Co.
22. BioControl Medical
23. Brainsway
24. Bristol-Myers Squibb Co.
25. Caeden, Inc.
26. Darta Systems
27. Electromedical Products International Inc.
28. Eli Lilly and Company
29. F. Hoffmann-La Roche AG
30. Fisher Wallace Laboratories, Inc.
31. GlaxoSmithKline PLC
32. H. Lundbeck A/S
33. Headspace, Inc.
34. Johnson & Johnson Services, Inc.
35. Lief Therapeutics
36. Lupin Pharmaceuticals, Inc.
37. MAG & More GmbH
38. MagVenture, Inc.
39. Merck & Co., Inc.
40. Mood Tracker Web Media, LLC
41. Mylan N.V
42. Neuronetics, Inc.
43. NeuroSigma, Inc.
44. Neuvana, LLC
45. Allergan PLC
46. Otsuka Pharmaceutical Co., Ltd.
47. Personal Zen
48. Prana Tech LLC
49. Sanvello Health, Inc.
50. Spire, Inc.
51. Takeda Pharmaceutical Co. Ltd.
Companies Profiled in the Report
1. Cerner
2. Netsmart
3. Core Solutions
4. Mindlinc
5. Nextgen Healthcare
6. The Echo Group
7. Valant
8. Welligent
9. Qualifacts Systems Inc.,
10. Credible
11. Meditab
12. Kareo
13. Compulink
14. Advance Data Systems
List of Companies Mentioned in the Report:
1. Cerner
2. Netsmart
3. Core Solutions
4. Mindlinc
5. Nextgen Healthcare
6. The Echo Group
7. Valant
8. Welligent
9. Qualifacts Systems Inc.,
10. Credible
11. Meditab
12. Kareo
13. Compulink
14. Advance Data Systems
15. Advancedmd
16. Abbott Laboratories Inc.
17. Alkermes PLC
18. AstraZeneca PLC
19. Azumio Inc.
20. Bausch Health Companies, Inc.
21. Beijing PINS Medical Co.
22. BioControl Medical
23. Brainsway
24. Bristol-Myers Squibb Co.
25. Caeden, Inc.
26. Darta Systems
27. Electromedical Products International Inc.
28. Eli Lilly and Company
29. F. Hoffmann-La Roche AG
30. Fisher Wallace Laboratories, Inc.
31. GlaxoSmithKline PLC
32. H. Lundbeck A/S
33. Headspace, Inc.
34. Johnson & Johnson Services, Inc.
35. Lief Therapeutics
36. Lupin Pharmaceuticals, Inc.
37. MAG & More GmbH
38. MagVenture, Inc.
39. Merck & Co., Inc.
40. Mood Tracker Web Media, LLC
41. Mylan N.V
42. Neuronetics, Inc.
43. NeuroSigma, Inc.
44. Neuvana, LLC
45. Allergan PLC
46. Otsuka Pharmaceutical Co., Ltd.
47. Personal Zen
48. Prana Tech LLC
49. Sanvello Health, Inc.
50. Spire, Inc.
51. Takeda Pharmaceutical Co. Ltd.
List of Organizations Mentioned in the Report
1. NCBI (National Center for Biotechnology Information)
2. Mayo Clinic
3. cancersupportcommunity.org
4. Cancer Treatment Centers of America
5. Cancer.gov
6. World Health Organization (WHO)
7. European Commission
8. World Bank
9. Biotech trade organizations
10. Biotech innovation organizations
11. Cancer.org
12. Centers for Disease Control and Prevention (CDC)
13. National Institutes of Health (NIH)
14. World Health Organization (WHO)
15. Free Patent Online
16. Clinicaltrial.gov
17. Medanta.org
18. Chcrr.org
19. Cancerresearchuk.org
20. clevelandclinic.org
21. virginiamason.org
22. uofmhealth.org
1. Cerner
2. Netsmart
3. Core Solutions
4. Mindlinc
5. Nextgen Healthcare
6. The Echo Group
7. Valant
8. Welligent
9. Qualifacts Systems Inc.,
10. Credible
11. Meditab
12. Kareo
13. Compulink
14. Advance Data Systems
List of Companies Mentioned in the Report:
1. Cerner
2. Netsmart
3. Core Solutions
4. Mindlinc
5. Nextgen Healthcare
6. The Echo Group
7. Valant
8. Welligent
9. Qualifacts Systems Inc.,
10. Credible
11. Meditab
12. Kareo
13. Compulink
14. Advance Data Systems
15. Advancedmd
16. Abbott Laboratories Inc.
17. Alkermes PLC
18. AstraZeneca PLC
19. Azumio Inc.
20. Bausch Health Companies, Inc.
21. Beijing PINS Medical Co.
22. BioControl Medical
23. Brainsway
24. Bristol-Myers Squibb Co.
25. Caeden, Inc.
26. Darta Systems
27. Electromedical Products International Inc.
28. Eli Lilly and Company
29. F. Hoffmann-La Roche AG
30. Fisher Wallace Laboratories, Inc.
31. GlaxoSmithKline PLC
32. H. Lundbeck A/S
33. Headspace, Inc.
34. Johnson & Johnson Services, Inc.
35. Lief Therapeutics
36. Lupin Pharmaceuticals, Inc.
37. MAG & More GmbH
38. MagVenture, Inc.
39. Merck & Co., Inc.
40. Mood Tracker Web Media, LLC
41. Mylan N.V
42. Neuronetics, Inc.
43. NeuroSigma, Inc.
44. Neuvana, LLC
45. Allergan PLC
46. Otsuka Pharmaceutical Co., Ltd.
47. Personal Zen
48. Prana Tech LLC
49. Sanvello Health, Inc.
50. Spire, Inc.
51. Takeda Pharmaceutical Co. Ltd.
List of Organizations Mentioned in the Report
1. NCBI (National Center for Biotechnology Information)
2. Mayo Clinic
3. cancersupportcommunity.org
4. Cancer Treatment Centers of America
5. Cancer.gov
6. World Health Organization (WHO)
7. European Commission
8. World Bank
9. Biotech trade organizations
10. Biotech innovation organizations
11. Cancer.org
12. Centers for Disease Control and Prevention (CDC)
13. National Institutes of Health (NIH)
14. World Health Organization (WHO)
15. Free Patent Online
16. Clinicaltrial.gov
17. Medanta.org
18. Chcrr.org
19. Cancerresearchuk.org
20. clevelandclinic.org
21. virginiamason.org
22. uofmhealth.org
Download sample pages
Complete the form below to download your free sample pages for Behavioural Health Market Report to 2031Related reports
Mental Disorder Drugs Market Report 2021-2031
Rising prevalence of mental disorders; mounting investment in drug R&D by pharmaceutical & biopharmaceutical companies; growing mental health care awareness;...Full DetailsPublished: 12 February 2021Cannabidiol Market Report 2020-2030
Where is the Cannabidiol Market heading? If you are involved in this sector you must read this newly updated report....
Full DetailsPublished: 01 January 1970CNS Therapeutics Market Report 2021-2031
Due to the rapid transmittal of the disease, there has been a sharp increase in number of cases worldwide. While...Full DetailsPublished: 25 January 2021Behavioral/Mental Health Care Software & Services Market Report 2019-2029
Behavioral/Mental Health Care Software & Services Report is a specialized and in-depth study of the medical devices industry with a...
Full DetailsPublished: 01 January 1970
Download sample pages
Complete the form below to download your free sample pages for Behavioural Health Market Report to 2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033
The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.
25 September 2023
Visiongain Publishes Anti-infective Vaccines Market Report 2023-2033
The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.
21 September 2023
Visiongain Publishes Contract Research Organisations (CROs) Market Report 2023-2033
The global Contract Research Organisations (CROs) market was valued at US$68.9 billion in 2023 and is projected to grow at a CAGR of 10.6% during the forecast period 2023-2033.
14 September 2023
Visiongain Publishes Stem Cell Therapy Contract Manufacturing Market Report 2023-2033
The global Stem Cell Therapy Contract Manufacturing market was valued at US$2,495.1 million in 2022 and is projected to grow at a CAGR of 12.4% during the forecast period 2023-2033.
13 September 2023
